Methylphenidate Off-Label Use and Safety

SpringerPlus - Germany
doi 10.1186/2193-1801-3-286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evidence for the Off-Label Use of Methylphenidate for Cognitive Enhancement in Healthy Individuals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Reasons for and Frequency of Off - Label Drug Use

Medicinski Pregled
Medicine
2015English

Innovation and Off‐label Use, the French Case and More

British Journal of Clinical Pharmacology
Pharmacology
2019English

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Off-Label Use of Medicinal Products - Legal Rules and Practices

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy